Want to join the conversation?
$AGN said FDA has approved Botox (onabotulinumtoxinA) for treatment of lower limb spasticity in adult patients to decrease severity of increased muscle stiffness in ankle and toe muscles. Botox is first and only botulinum toxin product to be approved by FDA to treat multiple muscle groups of upper and lower limbs that may be impacted by spasticity.
Visa ($V) set to release it earning after market close today. With new CEO resigning so close to the earnings, should we expect to see any surprises? Visa has been making strong moves with Visa Europe acquisition, partnership with PayPal and a 15% increase if quarterly dividends.
Kimberly Clark Corp ($KMB) has been in decline for most of the year, the stock has also not been getting any analyst love. Will today’s earnings break the trend? Revenue has been up and down in the last four quarters, let us see what this quarter brings.
$KMB down close to 4% after it misses on earnings and revenue. Forecasts are lower for the year.